XML 16 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues:        
Product revenue, net $ 345   $ 345  
Revenue from Contract with Customer, Product and Service [Extensible Enumeration] us-gaap:ProductMember   us-gaap:ProductMember  
Grant revenue   $ 285   $ 285
Total revenues $ 345 285 $ 345 285
Operating expenses:        
Cost of sales 172   172  
Research and development 24,914 12,853 70,637 30,646
Selling, general and administrative 29,940 10,350 86,284 24,012
Total operating expenses 55,026 23,203 157,093 54,658
Loss from operations (54,681) (22,918) (156,748) (54,373)
Other income (expense), net:        
Interest income 601 3 1,134 6
Change in fair value of convertible notes       (5,228)
Other income (expense), net 199 (227) 138 8
Total other income (expense), net 800 (224) 1,272 (5,214)
Loss before income taxes (53,881) (23,142) (155,476) (59,587)
(Benefit) provision for income taxes (125)   195  
Net loss $ (53,756) $ (23,142) $ (155,671) $ (59,587)
Net loss per share attributable to common stockholders -basic $ (0.92) $ (3.42) $ (2.77) $ (9.20)
Net loss per share attributable to common stockholders -diluted $ (0.92) $ (3.42) $ (2.77) $ (9.20)
Weighted-average shares used in computing net loss per share attributable to common stockholders-basic 58,533,226 6,757,152 56,163,194 6,477,140
Weighted-average shares used in computing net loss per share attributable to common stockholders-diluted 58,533,226 6,757,152 56,163,194 6,477,140